News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
772,988 Results
Type
Article (51783)
Company Profile (272)
Press Release (720921)
Multimedia
Podcasts (117)
Webinars (20)
Section
Business (213114)
Career Advice (2129)
Deals (36756)
Drug Delivery (143)
Drug Development (84247)
Employer Resources (174)
FDA (17378)
Job Trends (15864)
News (361281)
Policy (34941)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2837)
Accelerated approval (55)
ADA (44)
Adcomms (34)
Allergies (200)
Alliances (51768)
ALS (234)
Alzheimer's disease (1906)
Antibody-drug conjugate (ADC) (534)
Approvals (17856)
Artificial intelligence (767)
ASCO (333)
Autoimmune disease (356)
Automation (65)
Bankruptcy (377)
Best Places to Work (12095)
BIO (67)
BIOSECURE Act (20)
Biosimilars (236)
Biotechnology (171)
Bladder cancer (207)
Brain cancer (78)
Breast cancer (825)
Cancer (6448)
Cardiovascular disease (527)
Career advice (1821)
Career pathing (48)
CAR-T (361)
CDC (65)
Celiac Disease (3)
Cell therapy (980)
Cervical cancer (58)
Clinical research (73603)
Collaboration (2285)
Commercialization (1)
Company closure (5)
Compensation (1503)
Complete response letters (87)
COVID-19 (2885)
CRISPR (118)
C-suite (1278)
Cystic fibrosis (157)
Data (8758)
Decentralized trials (3)
Denatured (42)
Depression (186)
Dermatology (99)
Diabetes (678)
Diagnostics (7261)
Digital health (67)
Diversity (14)
Diversity, equity & inclusion (46)
Drug discovery (364)
Drug pricing (213)
Drug shortages (34)
Duchenne muscular dystrophy (310)
Earnings (94456)
Editorial (72)
Employer branding (21)
Employer resources (156)
Events (125864)
Executive appointments (1157)
FDA (21515)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1900)
Gene editing (251)
Generative AI (69)
Gene therapy (764)
GLP-1 (1163)
Government (5044)
Grass and pollen (6)
Guidances (423)
Healthcare (20242)
Hematology (194)
HIV (94)
Huntington's disease (63)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (111)
Immunology and inflammation (308)
Immuno-oncology (108)
Indications (223)
Infectious disease (3264)
Inflammatory bowel disease (231)
Inflation Reduction Act (14)
Influenza (146)
Intellectual property (321)
Interviews (329)
IPO (17050)
IRA (51)
Job creations (4065)
Job search strategy (1511)
JPM (58)
Kidney cancer (20)
Labor market (112)
Layoffs (597)
Leadership (44)
Legal (8513)
Liver cancer (107)
Longevity (36)
Lung cancer (858)
Lymphoma (480)
Machine learning (67)
Management (61)
Manufacturing (1179)
Marketing (4)
MASH (216)
Medical affairs (1)
Medical device (15042)
Medtech (15224)
Mergers & acquisitions (21036)
Metabolic disorders (1708)
mRNA (242)
Multiple sclerosis (203)
NASH (17)
Neurodegenerative disease (478)
Neuropsychiatric disorders (115)
Neuroscience (3598)
Neurotech (1)
NextGen: Class of 2026 (6925)
Non-profit (4801)
Now hiring (82)
Obesity (793)
Opinion (316)
Ovarian cancer (244)
Pain (273)
Pancreatic cancer (360)
Parkinson's disease (408)
Partnered (37)
Patents (645)
Patient recruitment (791)
Peanut (69)
People (62858)
Pharmaceutical (61)
Pharmacy benefit managers (34)
Phase 1 (22926)
Phase 2 (32349)
Phase 3 (24130)
Pipeline (9992)
Policy (342)
Postmarket research (2747)
Preclinical (9769)
Press Release (67)
Prostate cancer (343)
Psychedelics (61)
Radiopharmaceuticals (357)
Rare diseases (1212)
Real estate (6372)
Recruiting (71)
Regulatory (27368)
Reports (56)
Research institute (2590)
Resumes & cover letters (364)
Rett syndrome (46)
RNA editing (25)
RSV (93)
Schizophrenia (190)
Series A (321)
Series B (238)
Service/supplier (12)
Sickle cell disease (123)
Special edition (25)
Spinal muscular atrophy (174)
Sponsored (50)
Startups (3905)
State (2)
Stomach cancer (19)
Supply chain (140)
Tariffs (90)
The Weekly (73)
Vaccines (1199)
Venture capital (124)
Weight loss (522)
Women's health (144)
Worklife (21)
Date
Today (123)
Last 7 days (497)
Last 30 days (2462)
Last 365 days (31037)
2026 (16573)
2025 (30904)
2024 (36076)
2023 (41142)
2022 (52382)
2021 (57097)
2020 (55910)
2019 (48792)
2018 (36935)
2017 (33744)
2016 (33563)
2015 (39608)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (820)
Alabama (95)
Alaska (7)
Arizona (379)
Arkansas (16)
Asia (43199)
Australia (7126)
California (14157)
Canada (3993)
China (1557)
Colorado (616)
Connecticut (634)
Delaware (441)
Europe (94298)
Florida (2138)
Georgia (458)
Hawaii (3)
Idaho (67)
Illinois (1215)
India (100)
Indiana (643)
Iowa (25)
Japan (610)
Kansas (137)
Kentucky (53)
Louisiana (59)
Maine (76)
Maryland (1709)
Massachusetts (10230)
Michigan (390)
Minnesota (788)
Mississippi (7)
Missouri (152)
Montana (33)
Nebraska (30)
Nevada (154)
New Hampshire (90)
New Jersey (3743)
New Mexico (32)
New York (3737)
North Carolina (1860)
North Dakota (9)
Northern California (7146)
Ohio (423)
Oklahoma (24)
Oregon (42)
Pennsylvania (2806)
Puerto Rico (31)
Rhode Island (54)
South America (1202)
South Carolina (89)
South Dakota (2)
Southern California (5612)
Tennessee (236)
Texas (2296)
United States (50384)
Utah (421)
Vermont (2)
Virginia (351)
Washington D.C. (84)
Washington State (1155)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
772,988 Results for "solta medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bausch Health’s Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China
May 29, 2026
·
5 min read
Press Releases
Bausch Health’s Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China
December 2, 2025
·
4 min read
Press Releases
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
Integration into McKesson’s Medical-Surgical Solutions marketplace serving a nationwide customer base
June 30, 2026
·
6 min read
Press Releases
Bausch Health’s Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
September 8, 2025
·
5 min read
Press Releases
Belmont Medical Completes Acquisition of Arcos, Inc.
June 17, 2026
·
4 min read
Press Releases
Bausch Health Announces Launch of Solta Medical’s Fraxel FTX(TM)
April 28, 2025
·
7 min read
Policy
Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
Bausch Health Companies Inc. and Solta Medical, a global leader in the medical aesthetics market, announced the approval of Thermage® FLX and the TR-4 Return Pad by China’s National Medical Products Administration.
January 18, 2024
·
5 min read
Press Releases
Novanta Inc. Announces Acquisition of Riverpoint Medical
June 9, 2026
·
12 min read
Press Releases
Tenon Medical, Inc. Announces Pricing of $4.2 Million Public Offering
June 30, 2026
·
5 min read
Policy
CORRECTION BY SOURCE: Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China
Bausch Health Companies Inc. and Solta Medical, a global leader in the medical aesthetics market, announced the approval of Thermage® FLX and the TR-4 Return Pad by China’s National Medical Products Administration.
January 18, 2024
·
5 min read
1 of 77,299
Next
